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Secretagogin (SCGN), a Ca2 + -binding protein having six
EF-hands, is selectively expressed in pancreatic β-cells and
neuroendocrine cells. Previous studies suggested that SCGN
enhances insulin secretion by functioning as a Ca2 + -sensor
protein, but the underlying mechanism has not been elucidated.
The present study explored the mechanism by which SCGN
enhances glucose-induced insulin secretion in NIT-1 insulinoma
cells. To determine whether SCGN influences the first or second
phase of insulin secretion, we examined how SCGN affects
the kinetics of insulin secretion in NIT-1 cells. We found that
silencing SCGN suppressed the second phase of insulin secretion
induced by glucose and H2O2, but not the first phase induced by
KCl stimulation. Recruitment of insulin granules in the second
phase of insulin secretion was significantly impaired by knocking
down SCGN in NIT-1 cells. In addition, we found that SCGN
interacts with the actin cytoskeleton in the plasma membrane and
regulates actin remodelling in a glucose-dependent manner. Since
actin dynamics are known to regulate focal adhesion, a critical
step in the second phase of insulin secretion, we examined the
effect of silencing SCGN on focal adhesion molecules, including
FAK (focal adhesion kinase) and paxillin, and the cell survival
molecules ERK1/2 (extracellular-signal-regulated kinase 1/2) and
Akt. We found that glucose- and H2O2-induced activation of FAK,
paxillin, ERK1/2 and Akt was significantly blocked by silencing
SCGN. We conclude that SCGN controls glucose-stimulated
insulin secretion and thus may be useful in the therapy of Type 2
diabetes.
Key words: actin, calcium-binding protein, focal adhesion, insulin
secretion, secretagogin.
INTRODUCTION
Impaired insulin secretion in pancreatic β-cells is a major feature
of Type 2 diabetes. It is therefore important to understand the
mechanism by which insulin secretion is regulated in β-cells.
Glucose-stimulated insulin secretion (GSIS) from pancreatic β-
cells occurs in two phases: (i) a rapidly and transiently initiated
triggering pathway of pre-docked insulin granules near the plasma
membrane induced by KCl; and (ii) a gradually developed
and sustained amplifying pathway of newly recruited insulin
granules to the plasma membrane, from intracellular reserve
pool of granules, by glucose stimulation [1,2]. Because F-actin
(filamentous actin) forms a dense web underneath the plasma
membrane as a negative barrier, cortical F-actin remodelling is
required for the recruitment of the reserve pool granules to the
release site at the plasma membrane in the second phase of insulin
exocytosis [3]. In this phase, glucose triggers the Ca2 + influx
which controls the dynamic structure of the actin cytoskeleton
and thereby regulates the release of insulin granules [4,5].
FAK (focal adhesion kinase) plays a critical role in the
regulation of F-actin remodelling and insulin secretion [6,7]. In
pancreatic β-cells, integrin β1-mediated intracellular signalling
activates and phosphorylates FAK and paxillin upon glucose
stimulation. Additionally, these molecules form focal adhesion
complexes at the specific focal contact sites and activate
ERK1/2 (extracellular-signal-regulated kinase) and Akt signalling
pathways acting downstream of glucose-induced FAK activation
[7]. This signalling contributes to the regulation of the
insulin secretion by inducing actin cytoskeletal remodelling.
An in vivo study using β-cell-specific FAK-knockout mice
confirmed the essential role of the FAK-mediated pathway in
GSIS [8]. Furthermore, remodelling of focal adhesion is also
inhibited by agents such as jasplakinolide and latrunculin B
that respectively block actin cytoskeleton polymerization and
depolymerization [7].
In pancreatic β-cells, intracellular Ca2 + plays an essential
role in insulin secretion as a second messenger [9,10], and
proteins that bind to intracellular Ca2 + function as Ca2 + signal
transducers [11]. Secretagogin (SCGN), a recently cloned Ca2 + -
binding protein having six EF-hands, is exclusively expressed
in pancreatic β-cells and neuroendocrine cells [12]. SCGN is
proposed as a Ca2 + -sensor protein, because it has low Ca2 +
affinity and undergoes conformational changes to control protein–
protein interactions and cellular signalling processes [13]. The
function of Ca2 + -sensor proteins in regulating secretion is to
transduce Ca2 + signals to exocytotic machinery during the release
process in neuroendocrine and endocrine systems [14,15]. In
pancreatic β-cells, intracellular Ca2 + concentration is rapidly
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increased in the first phase of insulin secretion, whereas the
second phase requires oscillations of intracellular Ca2 + in addition
to amplifying signals from glucose metabolism [16]. Recently,
the expression level of SCGN in mouse insulinoma MIN6 cells
was shown to control GSIS [17]. However, the exact biological
function of SCGN as a Ca2 + -sensor protein in pancreatic β-cells
in exerting its positive effect on insulin secretion is not clear. In
the present study, we tried to elucidate the molecular mechanisms
underlying the regulation of insulin secretion by SCGN and the
associated subcellular pathways, employing NIT-1 insulinoma
cells as a model of insulin secretion [18–22].
MATERIALS AND METHODS
Antibodies and reagents
Anti-SCGN antibody was from AbFrontier. Anti-FAK, anti-
paxillin, anti-phospho-paxillin (Tyr118), anti-ERK1/2, anti-
phospho-ERK1/2 (Thr202/Tyr204), anti-Akt and anti-phospho-Akt
(Ser473) antibodies were from Cell Signaling Technology. Anti-
α-tubulin antibody, anti-β-actin antibody and normal rabbit IgG
were from Santa Cruz Biotechnology. Anti-phospho-FAK (Tyr397)
and anti-SCGN antibodies used in immunoprecipitation were
from Abcam. Anti-paxillin antibody used in confocal microscopy
was from Millipore Corporation. Anti-E-cadherin (epithelial
cadherin) and anti-N-cadherin (neural cadherin) antibodies were
from BD Biosciences. Horseradish peroxidase-conjugated goat
anti-mouse IgG and goat anti-rabbit IgG were from Bio-Rad
Laboratories. Rhodamine–phalloidin, Alexa Fluor® 488- or Alexa
Fluor® 568-conjugated goat anti-rabbit IgG and Alexa Fluor®
488-conjugated goat anti-mouse IgG were from Invitrogen.
Latrunculin B was from Calbiochem. Cytochalasin D, ionomycin
and DMSO from Sigma–Aldrich. Penicillin G, streptomycin,
FBS and trypsin were from Gibco Life Technologies. DMEM
(Dulbecco’s modified Eagle’s medium) and 45% D-glucose
were from WelGENE. SMARTpool siRNA and DharmaFECT1
transfection reagent were from Dharmacon. Insulin ELISA kit was
from ALPCO. BCA protein assay was from Thermo Scientific.
Protein G–Sepharose beads and silver staining kit were from GE
Healthcare.
Cell culture
NIT-1 β-cells were grown and maintained in 5.6 mM glucose
in DMEM supplemented with 10% (v/v) FBS, 100 μg/ml
streptomycin and 100 units/ml penicillin G at 37 ◦C under an
atmosphere of 5% CO2 in air
Islet isolation and primary cell culture
Mouse islets were isolated from 8–10-week-old C57BL/6 mice
by collagenase P perfusion and digestion as described previously
[23]. Individual islets were hand-picked using micropipettes
and cultured in RPMI 1640 medium supplemented with 10%
(v/v) FBS and 100 μg/ml penicillin/streptomycin for 24 h before
further experiments.
Knockdown of SCGN
ON-TARGETplus SMARTpool mouse SCGN siRNAs (25 nM)
were used to knock down SCGN in NIT-1 insulinoma cells. ON-
TARGETplus Non-targeting Pool siRNAs were used as control.
Silencing was achieved using DharmaFECT 1 transfection reagent
according to the manufacturer’s recommendations. Changes in
the expression of SCGN in NIT-1 cells were analysed 48 h
after siRNA transfection. For mouse primary islet cells, Accell
siRNAs (Dharmacon) were used. Dispersed mouse islet cells
were treated with the non-targeting pool or Accell mouse
SCGN siRNA SMART pool (1 μM) in RPMI 1640 medium
containing 100 μg/ml penicillin/streptomycin and incubated
for 96 h.
Insulin secretion assay
NIT-1 cells were pre-incubated at 37 ◦C for 2 h with glucose-free
HBSS (Hanks balanced salt solution: 137 mM NaCl, 5.4 mM KCl,
1.26 mM CaCl2, 0.98 mM MgSO4, 0.44 mM KH2PO4, 0.36 mM
Na2HPO4 and 4.2 mM NaHCO3, pH 7.4). Following glucose
starvation, the cells were stimulated at 37 ◦C for 5–45 min with
HBSS containing various concentrations of D-glucose or H2O2.
After stimulation for the indicated period, insulin secreted into the
medium was measured using an insulin ELISA kit following the
manufacturer’s protocol. All medium extracts were normalized to
cellular total protein concentration. The protein concentration of
each sample was measured by a BCA protein assay performed
according to the manufacturer’s instructions.
Transmission electron microscopy
The cells were fixed with 2.5% (w/v) glutaraldehyde in HBSS
overnight at 4 ◦C and then stained with 2% (w/v) osmium
tetroxide in 0.1 M cacodylate buffer for 1 h. The cells were
dehydrated with ethanol series, infiltrated with Spurr’s resin
series, and polymerized at 60 ◦C over 8 h. The cell embedded
resin was cut with a diamond knife on ultramicrotome (Ultracuts).
The sections were mounted directly on 150 mesh copper grids,
stained with 2% (w/v) uranyl acetate in 50%methanol for 20 min
and Reynold’s lead citrate for 10 min. The grids were examined
using a Tecnai F20 transmission electron microscope (FEI) at
200 kV.
SDS/PAGE and Western blot analysis
Proteins were separated by SDS/PAGE (12% gel) and
immediately transferred on to a PVDF membrane. The membrane
was blocked with 5% (w/v) BSA and 0.1% Tween 20-
containing PBS for 1 h and sequentially incubated for 2 h at
room temperature, with each primary antibody diluted in PBST
(PBS buffer containing 3% BSA and 0.1% Tween 20) according
to the manufacturer’s instructions. In the case of some primary
antibodies, the incubation was allowed overnight at 4 ◦C. After
washing three times with PBS containing 0.1%Tween 20 (10 min
for each), the membrane was incubated with secondary goat anti-
mouse or rabbit antibody, diluted 1:5000 in PBS containing 0.1%
Tween 20 for 40 min at room temperature, and washed again
three times. The immune complexes were detected with LAS-
3000s (Fuji Photo Film) using a WEST-zol®plus Western Blot
Detection System (iNtRON Biotechnology).
Immunoprecipitation from cell extracts
NIT-1 cells were harvested and lysed with immunoprecipitation
buffer (150 mM NaCl, 50 mM Tris/HCl and 60 mM octyl β-D-
glucopyranoside, pH 7.4) containing protease inhibitors (1 mM
PMSF, 5 mM Na3VO4, 5 mM NaF, 5 μg/ml aprotinin, 10 μg/ml
leupeptin and 10 μg/ml pepstatin A) and HDAC (histone
deacetylase) inhibitors [10 μM TSA (trichostatin A) and 10 mM
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SB (sodium butyrate)] for 30 min on ice. The cell lysates were
centrifuged at 16000 g for 15 min at 4 ◦C. The supernatant was
incubated with normal rabbit IgG or anti-SCGN antibody for 2 h
at 4 ◦C followed by 1 h of incubation with Protein G–Sepharose
beads at 4 ◦C. The beads were then washed three times with 1 ml
of lysis buffer for removing non-specific binding and additionally
twice with 1 ml of lysis buffer without any detergent. The
immune complex was solubilized in non-reducing SDS gel sample
buffer and then boiled at 95 ◦C for 5 min. Samples separated on
SDS/PAGE (12% gel) were visualized using a silver staining kit
or by Western blot analysis.
Protein identification by nanoUPLC–ESI–q-TOF–tandem MS
In order to identify interacting proteins, the silver-stained protein
bands of immune complex on SDS/PAGE were destained and
digested with trypsin and the resulting peptides were extracted and
analysed by nanoAcquityTM ESI-q-TOF tandem MS (SYNAPTTM
HDMSTM, Waters) as described previously [24].
Confocal microscopy
NIT-1 cells were grown on SecureslipTM (Sigma) cell culture glass
coverslips to 70% confluence and gently washed twice with ice-
cold HBSS, and then fixed with 4% (w/v) paraformaldehyde
in HBSS for 10 min at room temperature. After washing with
HBSS, cells were permeabilized with 0.1% Triton X-100 in
HBSS for 10 min at room temperature. After washing with PBS,
non-specific protein adsorption was blocked by incubation with
3% (w/v) BSA, 0.2% Tween 20 and 0.2% gelatin in PBS for 1 h
at room temperature. For endogenous SCGN immunostaining,
polyclonal anti-SCGN antibody was diluted at 1:500 in PBS
containing 1% (w/v) BSA and 1% (w/v) sucrose. To visualize
F-actin, actin was labelled with red fluorescent rhodamine–
phalloidin. Cells were incubated with these primary antibodies
for 2 h at 37 ◦C. After washing three times with PBS for 10 min
each, cells were stained for 1 h at 37 ◦C with Alexa Fluor® 488-
(green) or 568- (red) conjugated goat anti-rabbit IgG diluted
1:50. After incubation, cells were washed three times with PBS.
ProLong Gold antifade reagent with DAPI (blue) was used for
mounting and nuclear staining. After mounting, the cells were
observed on a Zeiss LSM510 Meta laser-scanning microscope
using an EC plan-Neofluar ×100 oil-immersion objective. Images
were photographed and processed using LSM510 software
(Carl Zeiss).
Sucrose gradient fractionation
For each assay, one 100-mm plate of NIT-1 cells (4×106 cells)
was subjected to 5–42% (w/v) sucrose gradient in 10 mM HEPES
buffer, pH 7.4. The cells were starved with glucose-free HBSS for
2 h and immediately treated with DMSO or 2 μM ionomycin for
30 min in 16.8 mM glucose in HBSS. The cells were then washed
twice with ice-cold PBS and lysed with immunoprecipitation
buffer containing protease inhibitors (detailed above). The cell
lysates were passed through a 31 G needle five times using a 1 ml
syringe and incubated on ice for 30 min. Subsequently, 500 μl
of each lysate was layered on to 5–42% continuous sucrose
gradients and centrifuged at 4 ◦C in a swinging bucket SW41Ti
rotor (Beckman Coulter) at 100000 g for 16 h. Fractions were
collected from the top and subjected to Western blot analysis
using anti-SCGN and anti-β-actin antibodies.
F-actin/G-actin ratio measurement
NIT-1 cells were washed once with PBS and then lysed in
actin stabilization buffer (100 mM Pipes, pH 6.9, 5% glycerol,
5 mM MgCl2, 5 mM EGTA, 1% Triton X-100, 1 mM ATP
and protease inhibitors) pre-warmed at 37 ◦C and incubated
on a microtube shaking incubator for 10 min at 37 ◦C. The
lysates were centrifuged at 1000 g for 5 min at room temperature
using table top centrifuge. Immediately after removing non-
lysed cells, lysates were centrifuged at 100000 g for 1 h at
37 ◦C. The pellets containing F-actin were solubilized with actin
depolymerization buffer (100 mM Pipes, pH 6.9, 1 mM MgCl2,
10 mM CaCl2 and 5 μM cytochalasin D) and incubated for 1 h
on ice. The supernatant [G-actin (globular actin)] and pellet [F-
actin] fractions were separated by SDS/PAGE and subsequently
subjected to Western blot analysis with anti-β-actin antibody. The
cellular F-actin/G-actin ratio was estimated from the Western blot
analysis.
RESULTS
Secretagogin enhances glucose-stimulated insulin secretion in
β-cells
SCGN is suggested to enhance pancreatic insulin secretion
because tissues overexpressing SCGN increased insulin secretion
in previous studies [12,17]. However, the underlying mechanism
of SCGN’s action in insulin secretion has not been explored. In the
present study, we investigated whether SCGN is directly involved
in insulin secretion by modulating SCGN expression level in
NIT-1 β-cells, a mouse insulinoma cell line [25]. Since NIT-1
cells are too sensitive to overexpress proteins by transfection
and it is not possible to generate a virus-infected stable cell
line because glucose responsibility of insulin secretion is readily
decayed depending on the cell passages [18], SCGN expression
levels in NIT-1 cells were modulated by silencing with siRNA.
We employed a mixture of four different siRNA sequences to
target various regions of SCGN in this SCGN-depletion study. The
mixture of siRNA oligonucleotides was transiently transfected via
DharmaFECT1 reagent into NIT-1 cells to deplete endogenous
SCGN.
We first confirmed that SCGN is involved in insulin secretion by
modulating SCGN expression in NIT-1 cells. After transfection of
the siRNA mixture, NIT-1 cells were pre-incubated with glucose-
free HBSS for 2 h and then stimulated with various concentrations
of glucose. Depletion of SCGN resulted in a significant inhibition
of GSIS compared with the control in a glucose-dose-dependent
manner (Figure 1A). SCGN depletion was confirmed by Western
blot analysis with anti-SCGN using anti-α-tubulin antibody as
a loading control. For further confirmation, we employed low
concentrations of exogenous H2O2 (50 and 100 μM for 30 min)
which increase insulin secretion by raising intracellular ROS
(reactive oxygen species) levels as a glucose-mimicking stimulant
[26–29]. As shown in Figure 1B, treatment with H2O2 after
knocking down SCGN decreased insulin secretion. These results
confirm that SCGN is involved in glucose- and H2O2-responsive
insulin secretion. In order to validate the effects of SCGN
under physiological conditions, we investigate glucose-stimulated
insulin secretion using primary mouse islet cells. Isolated mouse
islets were dissociated into single cells by trypsinization and then
treated with either control or SCGN-specific Accell siRNA, a
lipid-conjugated siRNA directed against mouse SCGN. GSIS
was significantly impaired in the SCGN-depleted islet cells, in
agreement with our observations in NIT-1 cells (Figure 1C). These
results indicate that the GSIS response of NIT-1 cells parallels that
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Figure 1 Silencing secretagogin by siRNA leads to inhibition of GSIS in NIT-1 β-cells
NIT-1 cells were transfected with commercial SCGN siRNA or non-targeting control oligonucleotides. After 48 h of transfection, cells were pre-incubated with glucose-free HBSS for 2 h followed
by stimulation with the indicated concentration of glucose (A) or H2O2 (B) in HBSS for 30 min. Secreted insulin was measured and normalized to total cell protein concentration. Results are
means +− S.D. from triplicate experiments. *P < 0.05, **P < 0.01, ***P < 0.005. (C) GSIS in islet cells isolated from mice. Control or SCGN siRNA-treated islet cells (105) were starved with basal
glucose (3.3 mM) for 70 min and stimulated with glucose (16.7 mM) for 30 min keeping the temperature at 37◦C. Secreted medium was analysed for insulin concentration. Whole-cell detergent
lysates were subjected to Western blot analysis with anti-SCGN or anti-α-tubulin antibody as a loading control. All experiments were run in triplicates. Results are means +− S.D. *P < 0.005. CTL,
control.
of primary islet cells and that SCGN is required for GSIS in both
the pancreatic β-cell line and primary islets.
Secretagogin mediates the second phase of glucose-stimulated
insulin secretion
To determine the point at which SCGN is involved in insulin
secretion, we compared the effects of SCGN depletion on the
first and second phase of insulin secretion. Cellular insulin
secretion occurs in two phases: (i) a rapidly and transiently
initiated triggering pathway of pre-docked insulin granules near
the plasma membrane; and (ii) a gradually developed and
sustained amplifying pathway of newly recruited insulin granules
to the plasma membrane by glucose stimulation. Insulin secretion
induced by KCl stimulation is both faster and greater in the initial
phase than glucose stimulation, since KCl treatment causes only
first-phase release through direct depolarization of the plasma
membrane [30]. Second-phase insulin secretion is induced in
response to glucose, not KCl. KCl has been used to induce
the first phase of insulin secretion by membrane depolarization
followed by increased intracellular Ca2 + , whereas glucose is used
to evoke both first- and second-phase insulin release through
the KATP channel-independent amplification pathway [31–33].
To investigate the underlying defects of insulin secretion in
SCGN-knockdown NIT-1 cells, we compared insulin secretion
in response to KCl and glucose stimulation. SCGN-knockdown
NIT-1 cells were pre-incubated with 5.4 mM KCl or glucose-free
HBSS for 2 h, and then stimulated with 30 mM KCl or 16.8 mM
glucose for 30 min respectively. The amounts of secreted insulin
c© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution Licence 4.0
(CC BY-NC-ND).
Secretagogin regulates actin and FAK in insulin secretion 1795
were measured. Figure 2A shows that SCGN depletion impaired
GSIS (second phase), but not KCl-induced insulin secretion (first
phase).
We then compared the kinetics of insulin secretion in glucose-
stimulated control and SCGN depleted NIT-1 cells. Cells starved
in glucose-free HBSS for 2 h were stimulated with high glucose
(16.8 mM) for the times indicated and insulin secretion was
measured. As shown in Figure 2B, there was no discernible
difference in first-phase insulin secretion (<20 min) between
control and SCGN-depleted cells, whereas extensive decreases
in GSIS were detected in SCGN-knockdown cells in the second
phase of secretion. These results indicate that, at least in vitro,
SCGN is required for the second, glucose-stimulated, phase of
insulin secretion, but not for the first, KCl/depolarization-induced,
phase of insulin secretion in pancreatic β-cells.
We next examined insulin granule mobilization in the second
phase of GSIS using TEM analysis (Figure 2C). There was
no significant difference in the number of previously docked
insulin granules between control and SCGN-knockdown cells
under starved conditions. In contrast, the recruitment of insulin
granules in response to glucose was significantly reduced in the
cells lacking SCGN. These findings indicate that the glucose-
driven refilling process of insulin granules in the second phase is
impaired by silencing SCGN.
Secretagogin interacts with the actin cytoskeleton in response to
glucose and Ca2+ signals
It is known that mitochondrial metabolism is critical for the second
phase of insulin secretion, so we examined the mitochondrial
function through monitoring the changes of mitochondrial
membrane potential in response to glucose stimulation in control
and SCGN-knockdown NIT-1 cells. We found that mitochondrial
function in response to glucose was retained in SCGN-knockdown
NIT-1 cells as well as control cells (Supplementary Figure S1).
In order to determine how SCGN affects insulin secretion, we
examined protein–protein interactions with endogenous SCGN
in NIT-1 cells employing immunoprecipitation combined with
peptide sequencing by nanoUPLC (nano-ultra-performance liquid
chromatography)–ESI–q-TOF–tandem MS. NIT-1 cells were
lysed with a lysis buffer containing octyl β-D-glucopyranoside,
used in solubilization and isolation of membrane proteins in mild
conditions [34]. The cell lysates were immunoprecipitated with
anti-SCGN or control IgG antibody. The immune complexes
were separated by SDS/PAGE and detected by silver staining
(Figure 3A). Differentially appearing protein bands were
identified after digestion with trypsin, by peptide sequencing with
nanoUPLC–ESI–q-TOF–tandem MS. β-Actin (MS/MS spectrum
in Figure 3B), was specifically identified in the SCGN lane after
excluding the non-specific proteins in the control lane, and this
was confirmed by Western blot analysis (Figure 3C). Also, the
fact that actin was identified in the solubilized membrane proteins
using octyl β-D-glucopyranoside as a detergent without protein
denaturation suggests that actin–SCGN interaction occurs in the
plasma membrane.
Since the actin cytoskeleton is known to play a principal
regulatory role in the transport of insulin granules in the second
phase of GSIS [35,36], we examined the SCGN–actin interaction
further in response to glucose-stimulation. We found that the
binding of SCGN to actin was increased in response to glucose
stimulation (Figure 4A), which suggests that SCGN regulates
insulin secretion by binding to the actin cytoskeleton. We also
observed, employing confocal microscopy, that actin and SCGN
co-localized in NIT-1 cells following H2O2 stimulation which
mimics glucose signalling. Figure 4B shows that endogenous
Figure 2 Secretagogin mediates the second phase of insulin secretion
(A) SCGN depletion impairs insulin secretion induced by glucose, not by KCl. NIT-1 cells
transfected with non-targeting control or SCGN siRNA were pre-incubated with 5.4 mM KCl in
glucose-free HBSS at 37◦C for 2 h and then stimulated with 30 mM KCl or 16.8 mM glucose
in HBSS at 37◦C for 30 min. Secreted insulin was measured using the mouse ultrasensitive
insulin ELISA kit. Insulin content data were normalized to total cell protein concentration. Results
are means +− S.D. from triplicate samples. CTL, control. (B) Time course of insulin secretion
and its inhibition in SCGN-depleted cells in the second phase of insulin secretion. NIT-1 cells
transfected with control or SCGN siRNA were pre-incubated in glucose-free HBSS at 37◦C
for 2 h and then stimulated with 16.8 mM glucose in HBSS for the times indicated. Insulin
secretion was determined using the insulin ELISA kit. Results are means +− S.D. of triplicates.
*P < 0.05, ***P < 0.005. Silencing of SCGN was confirmed by Western blot analysis with
anti-SCGN antibody or anti-α-tubulin antibody as a loading control. CTL, control. (C) NIT-1
cells transiently transfected with control or SCGN siRNA were cultured on a glass-bottomed
chamber slide dish. The cells were pre-incubated with glucose-free HBSS for 2 h and stimulated
with 16.8 mM glucose for 35 min at 37◦C, followed by fixation with 2.5 % glutaraldehyde.
Electron micrographs were taken in non-stimulated (upper) or glucose-stimulated (lower)
control (left) and SCGN-knockdown (right) NIT-1 cells. White arrows indicate the pre-docked
insulin granules and black arrows indicate the recruitment of insulin granules. Scale bar,
0.5 μm.
c© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution Licence 4.0
(CC BY-NC-ND).
1796 S.-Y. Yang and others
Figure 3 Secretagogin interacts with actin cytoskeleton in NIT-1 cells
NIT-1 cells were harvested and lysed with a lysis buffer containing protease inhibitors. Cell lysates were subjected to immunoprecipitation (IP) with anti-SCGN or control IgG antibody. (A)
Immune complexes were separated by SDS/PAGE (12 % gel) under reducing conditions and visualized with silver staining. Molecular masses are indicated in kDa. (B) Tandem MS spectrum
of a peptide in β-actin. Differentially expressed protein bands between IgG and anti-SCGN antibody were extracted from gels, digested with trypsin and identified by peptide sequencing with
nanoUPLC–ESI–q-TOF–tandem MS. (C) Immune complexes were confirmed by Western blotting with anti-β-actin or anti-SCGN antibody.
SCGN was distributed throughout the cells in the basal condition
and was translocated from the cytosol to the plasma membrane
after H2O2 stimulation, enhancing further the co-localization
with the actin cytoskeleton in plasma membrane. Since glucose-
induced Ca2 + signalling is a critical step for insulin secretion,
we examined the effect of Ca2 + influx on the SCGN–actin
interaction by stimulating the cells with ionomycin which induces
actin polymerization with a rapid increase in the internal Ca2 +
level [37]. We used sucrose gradient fractionation to directly
analyse the distribution of the actin cytoskeleton and SCGN in
NIT-1 cells. NIT-1 cells were pre-incubated with glucose-free
HBSS for 2 h and subsequently treated with DMSO or 2 μM
ionomycin in 16.8 mM glucose in HBSS for 30 min. We next
fractionated the total cell lysates on 5–42% continuous sucrose
gradients, and determined the protein level in each fraction by
Western blotting (Figure 4C). We found that the distribution
of actin became denser after ionomycin treatment compared
with treatment with control DMSO, consistent with the fact
that ionomycin induces polymerization of actin cytoskeleton and
increases sedimentation of actin. The distribution of SCGN also
became denser after treatment with ionomycin, parallel to the actin
cytoskeleton (Figure 4C), indicating that Ca2 + influx induces co-
sedimentation of SCGN and the actin cytoskeleton by potentiating
actin polymerization.
Secretagogin modulates glucose-mediated actin dynamics
To determine whether SCGN plays a role in actin reorganization,
we assessed both F-actin and G-actin in NIT-1 cells, because
cytoskeletal remodelling is an essential step in insulin secretion,
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Figure 4 Glucose and Ca2+ stimulation enhances the interaction of
secretagogin with actin
(A) NIT-1 cells were treated with 0 or 16.8 mM glucose HBSS for 30 min after pre-incubation
with glucose-free HBSS for 2 h. The cell lysates were subjected to immunoprecipitation (IP) with
anti-SCGN antibody or control IgG. Immune complexes were separated by SDS/PAGE (12 % gel)
under reducing conditions and detected by Western blotting with anti-β-actin and anti-SCGN
antibodies. A representative blot from three independent experiments is shown. The relative
intensities of the β-actin bands were normalized to SCGN bands and expressed as a ratio.
Results are mean +− S.D. intensity ratios from three independent experiments. *P < 0.05. (B)
NIT-1 cells were starved with glucose-free HBSS for 2 h and stimulated with 0 or 100 μM H2O2
in glucose-free HBSS for 30 min at 37◦C. Cells were then fixed and stained for F-actin (red)
and SCGN (green) using rhodamine–phalloidin and anti-SCGN antibody. Scale bar, 10 μm. (C)
Sucrose gradient fractionation of total cell lysates from NIT-1 cells incubated with glucose-free
HBSS for 2 h and stimulated with DMSO or 2 μM ionomycin for 30 min in 16.8 mM glucose
in HBSS. Each fraction was separated by SDS/PAGE (12 % gel) and visualized by Western blot
analysis with anti-β-actin and anti-SCGN antibodies. For quantification of the distribution in
the gradient, relative protein levels in each fraction were calculated as percentage of the total
levels from all fractions using densitometry. Results are means +− S.D. from three independent
experiments.
not only for eliminating the pre-existing F-actin barrier, but also
for stabilizing actin polymerization in stress fibres serving as
routes for insulin granules toward the plasma membrane [38,39].
To obtain the F-actin and G-actin fractions, NIT-1 cells lysed
in warm actin stabilization buffer were centrifuged at 100000 g
for 1 h, separating F-actin going into the pellet and G-actin
remaining in the supernatant. The F-actin-containing pellet was
then solubilized with actin depolymerization buffer. The cellular
F-actin/G-actin ratio was estimated by Western blotting. The
amount of F-actin in the SCGN-knockdown NIT-1 cells was
discernibly decreased, indicating that SCGN affects the dynamics
of actin cytoskeleton in the pancreatic β-cell (Figure 5A). Since F-
actin reorganization plays a critical role in the regulation of GSIS
[4], we examined H2O2-induced actin cytoskeletal remodelling
in SCGN-knockdown NIT-1 cells using confocal microscopy.
As shown in Figure 5B, H2O2 stimulation led to a partial
depolymerization of the actin cytoskeleton at the cell periphery,
resulting in assembly of F-actin stress fibres. However, NIT-1
cells depleted of SCGN showed collapsed actin stress fibres which
accumulated at the cell periphery, and displayed a denser and more
intense structure, which possibly blocks the secretion of insulin
granules. These findings suggest that SCGN plays a regulatory
role in actin remodelling, causing GSIS in NIT-1 cells.
Secretagogin facilitates focal adhesion
On silencing endogenous SCGN, NIT-1 cells acquired a more
round and less spread morphology, as shown in Figure 6A.
We assessed the effects of this morphological change in NIT-1
cells on adherens junction components of the cadherin family.
These changes in cell morphology up-regulated the expression
of E-cadherin, a major component of adherens junctions, and
down-regulated N-cadherin expression in SCGN-knockdown
cells (Figure 6B). Such switches in E-cadherin and N-cadherin
expression are in agreement with alterations in cell–cell adhesion
molecules and junction organization predicted by morphological
changes [40].
Since changes in cellular morphology are known to modulate
local focal adhesion [41] and focal adhesion regulated by actin
cytoskeletal reorganization at the cell surface plays a crucial role in
GSIS [7,8,42], we investigated whether SCGN, which stimulates
insulin secretion, also affects focal adhesion formation. SCGN-
depleted and control NIT-1 cells were starved with glucose-
free HBSS and treated with H2O2 to induce insulin secretion,
and focal adhesion assemblies in these cells were compared,
employing immunofluorescence confocal microscopy. We used
paxillin as a marker of focal adhesion assembly at the plasma
membrane (Figure 6C). No focal adhesion assembly sites were
seen in SCGN-knockdown NIT-1 cells stimulated by H2O2,
whereas numerous dot-shaped focal adhesion sites were found
near the plasma membrane in the H2O2-stimulated control cells
(Figure 6C). These results suggest that SCGN plays a critical
role in generating the focal adhesion assembly induced by H2O2
stimulation.
Secretagogin is essential for the activation of focal adhesion
signalling
A previous study demonstrated that focal adhesion remodelling,
mediated by activated FAK, is essential for GSIS [6]. Since
depletion of SCGN inhibits the formation of focal adhesion
assembly induced by H2O2, a glucose-mimicking stimulant, we
examined the effects of silencing SCGN on the H2O2-induced
focal adhesion activation pathway including phosphorylation of
FAK (Tyr397) and paxillin (Tyr118) and its downstream signalling
effectors, including ERK1/2 (Thr202/Tyr204) and Akt (Ser473).
Since the focal adhesion signalling is a rapid and transient
response, we first examined the kinetics of phosphorylation of
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Figure 5 Intracellular actin remodelling is modulated by secretagogin
(A) F-actin and G- actin in NIT-1 cells treated with control or SCGN siRNA were fractionated and subjected to Western blot analysis with anti-β-actin antibody. IP, immunoprecipitation. The ratio of
F-actin to G-actin was measured by densitometry. Results are mean +− S.D. intensity values from three independent experiments. *P < 0.005. (B) NIT-1 cells transiently transfected with non-targeting
control or SCGN siRNA were seeded on cell culture glass coverslips. After 48 h, cells were pre-incubated in glucose-free HBSS for 2 h and treated with 0 or 100 μM H2O2 in glucose-free HBSS for
30 min at 37◦C. Cells were subsequently fixed and stained for F-actin (red) and SCGN (green) using rhodamine–phalloidin and anti-SCGN antibodies. Nucleus was visualized with DAPI (blue).
Scale bar, 10 μm.
focal adhesion signalling molecules. SCGN-knockdown NIT-1
cells were exposed to 100 μM H2O2 for various durations up to
30 min. The activation kinetics of FAK, paxillin, ERK1/2 and
Akt are shown in Figure 7A. These activations are saturated upon
short-term H2O2 stimulation (<15 min), and silencing SCGN
obviously decreased these activations. Next we examined these
activations at 15 min in a H2O2-dose-dependent manner. Silencing
SCGN in NIT-1 cells inhibited H2O2-stimulated phosphorylation
of focal adhesion molecules FAK and paxillin, as well as
the phosphorylation of ERK1/2 and Akt, downstream targets
of the focal adhesion proteins (Figure 7B). To confirm the
effect of SCGN silencing on the activation of focal adhesion
molecules, the experiments described above were performed
after exposing the cells to various concentrations of glucose.
The activation amplitudes of FAK, paxillin, ERK1/2 and Akt
in SCGN-depleted NIT-1 cells were significantly lower than in
control cells (Figure 7C). These results confirm that the activation
of focal adhesion molecules in response to glucose-stimulation is
regulated by SCGN in NIT-1 cells.
Secretagogin plays a role in focal adhesion signalling by
regulating the actin cytoskeleton
Actin cytoskeletal reorganization is known to be closely related
to GSIS and focal adhesion signalling [7,36,43]. Previous studies
found that the disruption of the dynamic equilibrium state of
actin polymerization blunts the activation of focal adhesion
signalling [5,7]. To determine whether SCGN affects focal
adhesion signalling via the actin cytoskeleton, we compared
glucose-induced activation of FAK and ERK in control and
c© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution Licence 4.0
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Figure 6 Secretagogin regulates cell morphology and focal adhesion
(A) Morphology of control or SCGN siRNA-transfected NIT-1 cells in culture. (B) Western blot analysis of cell adhesion molecules. Control or SCGN-knockdown NIT-1 cells were lysed in gel sample
buffer and subjected to Western blotting with the antibodies indicated. (C) Immunofluorescence analysis of the control or SCGN-knockdown NIT-1 cells starved with glucose-free HBSS for 2 h and
stimulated with 0 or 100 μM H2O2 in glucose-free HBSS for 15 min at 37◦C. Cells were subsequently fixed and stained for SCGN (red) and paxillin (green) using anti-SCGN and anti-paxillin
antibodies. Nuclei (blue) were stained with DAPI. Scale bar, 10 μm.
SCGN-knockdown cells, untreated or treated with latrunculin B,
an actin-depolymerizing reagent. As illustrated in Figure 8, actin
disruption induced by latrunculin B led to the blockage of the
glucose-stimulated phosphorylation of focal adhesion molecules
FAK and ERK, which was similar in both SCGN-knockdown
and control cells. These results suggest that SCGN promotes
focal adhesion signalling through the regulation of the actin
cytoskeleton.
DISCUSSION
In the present study, we have shown that SCGN, a Ca2 + -binding
protein having six EF-hands, regulates F-actin dynamics and
focal adhesion remodelling in pancreatic NIT-1 β-cells, thereby
promoting glucose- and H2O2-induced insulin secretion in these
cells. We showed further that SCGN plays a predominant role in
potentiating only the second phase of insulin secretion, without
altering the first phase of insulin release. The present study is
the first to demonstrate the involvement of SCGN in glucose-
mediated insulin secretion by remodelling actin and activating
focal adhesion molecules.
Ca2 + -binding proteins having EF-hand domains are effective
as buffers against increases in intracellular Ca2 + , and as Ca2 +
sensors that promote conformational changes triggering protein–
protein interactions and induce cell-state-specific signalling
events by Ca2 + [44]. This superfamily of 45 kDa Ca2 + -binding
proteins, which includes calretinin, calumenin, reticulocalbin
and SCGN, has been shown using bioinformatics analysis to
contain six EF-hands (results not shown). Of these, SCGN was
distinguished for acting in Ca2 + -dependent release mechanisms
such as insulin secretion from pancreatic β-cells [12,13,17,45]
and neurotransmitter secretion from nerve endings [12]. SCGN is
expressed exclusively in pancreatic β-cells and in neuroendocrine
cells. However, before the present study, little was known of the
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Figure 7 Focal adhesion signalling is significantly impaired by silencing secretagogin in NIT-1 cells
(A) The activation kinetics of focal adhesion molecules are regulated by SCGN. NIT-1 cells were transfected with siRNA against SCGN or control siRNA and maintained for 2 days. Cells were
incubated with glucose-free HBSS and stimulated with 100 μM H2O2 in glucose-free HBSS for the times indicated. Western blot analysis was carried out using the cell lysates with the antibodies
indicated. (B and C) Silencing SCGN inhibits glucose-induced phosphorylation of FAK, paxillin and downstream effectors of focal adhesion molecules. NIT-1 cells were transiently transfected with
control or SCGN siRNA. After 48 h, cells were incubated with glucose-free HBSS at 37◦C for 2 h and stimulated with various concentration of H2O2 (B) or glucose (C) in HBSS at 37◦C for 15 or
10 min respectively. Cells were then lysed with gel sample buffer. Proteins were resolved by SDS/PAGE (10 % gel) under reducing conditions and analysed by Western blotting using the indicated
antibodies. A representative blot from three independent experiments is shown. The relative intensities of the phosphorylated and total protein bands of starved and stimulated conditions were
quantified by densitometry and expressed as a ratio. Ratios were normalized to the control siRNA-transfected cells without any stimulation. Results are mean +− S.D. intensity values from three
independent experiments. *P < 0.05, **P < 0.01.
molecular mechanisms underlying SCGN’s action in pancreatic
β-cells or its role in insulin secretion. The present study
demonstrates (i) that SCGN controls the glucose-stimulated
second phase of insulin secretion, the pathway that mediates
ROS generation, but has no influence on the KCl-stimulated
pathway which provokes only the first phase of insulin secretion
[1,46]; (ii) that SCGN interacts with actin, which is potentiated
by glucose and intracellular Ca2 + signalling; and (iii) that SCGN
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Figure 8 Effects of actin cytoskeleton disruption with latrunculin B on focal
adhesion signalling are similar in SCGN-knockdown NIT-1 cells and control
cells
NIT-1 cells transfected with control or SCGN siRNA were starved with glucose-free HBSS
containing DMSO or 1 μM latrunculin B at 37◦C for 2 h and then stimulated with 0 or 16.8 mM
glucose in HBSS with DMSO or 1 μM latrunculin B at 37◦C for 10 min. The cell lysates
were dissolved in gel sample buffer and separated by SDS/PAGE (10 % gel) under reducing
conditions. Western blot analysis using the indicated antibodies was performed to show protein
expression.
and actin co-localize near the plasma membrane in response to
glucose stimulation. However, the binding mechanism of SCGN
and actin or the significance of their co-localization remains to be
elucidated.
GSIS in pancreatic β-cells involves remodelling of cortical
actin which transiently disrupts the interaction between
polymerized actin with the plasma membrane t-SNARE (target
soluble N-ethylmaleimide-sensitive fusion protein-attachment
protein receptor) complex. F-actin can have both positive and
negative roles in the process of insulin secretion depending
on the nature of F-actin remodelling [36]. After the rapid
and ready release of insulin granules beneath the plasma
membrane in the first phase of insulin secretion [30,47], the
second, glucose-stimulated, phase of insulin secretion requires
reorganization of the filamentous actin network for recruitment
of an intracellular storage pool of insulin granules towards
the plasma membrane [30,39,48]. Glucose stimulation induces
localized depolymerization of cortical F-actin, which acts as a
physical barrier impeding the access of insulin granules to the
cell periphery [35,38,48,49], as well as polymerization of F-
actin, which provides a cytoskeletal track for insulin granule
transport [50,51]. Silencing SCGN impairs glucose-induced
depolymerization of actin at the membrane, and significantly
reduces polymerization of actin in the central part of β-cells. In
accordance with this, F-actin was decreased in SCGN-knockdown
cells, indicating that the second phase of insulin secretion caused
by F-actin polymerization was blunted [52,53]. Our findings
suggest further that SCGN, which interacts with actin to promote
actin dynamics and stress fibre formation in response to glucose,
is necessary for the second phase of insulin secretion.
Actin polymerization is essential for cell adhesion [54,55] and
is closely involved in focal adhesion activation. Actin dynamics
and focal adhesion remodelling influence the second phase of
release of insulin granules [5–8]. Upon glucose stimulation, FAK
is activated by integrin β1-mediated intracellular signalling and
phosphorylates paxillin. The activated focal adhesion molecules
translocate to the plasma membrane, providing a molecular
scaffold for the actin cytoskeleton, and act in co-ordination
with F-actin remodelling to amplify the second phase of insulin
secretion [6,7,56]. In the present study, silencing SCGN in NIT-
1 cells blocked glucose-induced focal adhesion signalling in
a dose- and time-dependent manner. Knocking down SCGN
caused disruption of actin dynamics which in turn attenuated
focal adhesion and impaired insulin granule replenishment during
glucose stimulation. Considered together, these findings suggest
that SCGN modulates the activation of the upstream signal of
FAK-mediated focal adhesion by regulating actin cytoskeletal
reorganization and influences insulin secretion upon glucose
stimulation. Actin cytoskeletal reorganization via interaction
between SCGN and actin is required for the regulation of the
FAK-mediated signalling pathway, which in turn enhances the
second phase of insulin secretion in pancreatic β-cells. The
present study suggests that SCGN regulates F-actin dynamics
and focal adhesion remodelling in pancreatic β-cells, and thereby
the second phase of insulin secretion. Actin remodelling has
been demonstrated to play critical roles in vesicle trafficking
and the exocytotic process in many other secretory cells as well
[57–59]. Impaired secretion of insulin in pancreatic β-cells is a
major feature of Type 2 diabetes. The present study advances our
understanding of the mechanisms regulating insulin secretion by
β-cells, and our finding that SCGN plays a role in insulin secretion
suggests possible new approaches useful in the therapy of Type 2
diabetes.
In summary, the present study is the first to show that
SCGN performs a central regulatory function in the second
phase of glucose-stimulated insulin secretion and advances our
understanding of the basis for impaired glucose-stimulated insulin
secretion in islet β-cells. On the basis of the significant regulatory
role played by SCGN in insulin secretion, SCGN may be
potentially useful in the treatment of Type 2 diabetes.
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